HUT61009A - Process for producing 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient - Google Patents

Process for producing 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient

Info

Publication number
HUT61009A
HUT61009A HU9200069A HU9200069A HUT61009A HU T61009 A HUT61009 A HU T61009A HU 9200069 A HU9200069 A HU 9200069A HU 9200069 A HU9200069 A HU 9200069A HU T61009 A HUT61009 A HU T61009A
Authority
HU
Hungary
Prior art keywords
producing
active ingredient
same
pharmaceutical compositions
denotes
Prior art date
Application number
HU9200069A
Other languages
English (en)
Other versions
HU9200069D0 (en
Inventor
Louis Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of HU9200069D0 publication Critical patent/HU9200069D0/hu
Publication of HUT61009A publication Critical patent/HUT61009A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9200069A 1991-01-09 1992-01-08 Process for producing 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient HUT61009A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100201A FR2671349B1 (fr) 1991-01-09 1991-01-09 Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.

Publications (2)

Publication Number Publication Date
HU9200069D0 HU9200069D0 (en) 1992-03-30
HUT61009A true HUT61009A (en) 1992-11-30

Family

ID=9408550

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9200069A HUT61009A (en) 1991-01-09 1992-01-08 Process for producing 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient

Country Status (14)

Country Link
US (1) US5250543A (hu)
EP (1) EP0494816B1 (hu)
JP (1) JPH07113016B2 (hu)
KR (1) KR100225002B1 (hu)
AT (1) ATE182330T1 (hu)
AU (1) AU648134B2 (hu)
DE (1) DE69229607T2 (hu)
DK (1) DK0494816T3 (hu)
ES (1) ES2136614T3 (hu)
FR (1) FR2671349B1 (hu)
GR (1) GR3031173T3 (hu)
HU (1) HUT61009A (hu)
TW (1) TW197420B (hu)
UA (1) UA27719C2 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE4342195A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Dihydropyridine mit heterocyclisch substituierten Estern
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
FR2758558B1 (fr) * 1997-01-21 1999-04-16 Lafon Labor Nouveaux derives de la 1,4-dihydropyridine et leur utilisation en therapeutique
FR2781224B1 (fr) * 1998-07-17 2000-10-13 Lafon Labor 1,4-dihydropyridines a groupe sulfonamide
FR2781225B1 (fr) * 1998-07-17 2000-10-06 Lafon Labor 1,4-dihydropyridines a groupe carbonyl pyridine
FR2781226B1 (fr) * 1998-07-17 2000-10-13 Lafon Labor 1,4-dihydropyridines a groupe carbonyl benzodioxo
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
CN101643469B (zh) * 2008-12-27 2012-11-21 武汉百科药物开发有限公司 一种盐酸巴尼地平的合成工艺
CN109111431A (zh) * 2018-11-01 2019-01-01 山东仲鹊医药技术有限公司 一种盐酸巴尼地平化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
AU557175B2 (en) * 1982-10-15 1986-12-11 Kyowa Hakko Kogyo Co. Ltd. 2,6-dimethyl-4-(3-nitro phenyl)-1,4-dihydro pyridine-3,5- dicarboxylic acid esters
DE3303066A1 (de) * 1983-01-29 1984-12-06 Cassella Ag, 6000 Frankfurt Substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4808603A (en) * 1985-08-14 1989-02-28 Ciba-Geigy Corporation 3,5-diacyl-2,6-dialkyl-4-aryl-1,4-dihydropyridines, their use, and pharmaceutical compositions thereof
US4772596A (en) * 1986-10-09 1988-09-20 Sankyo Company Limited Dihydropyridine derivatives, their preparation and their use
JP2664941B2 (ja) * 1988-07-29 1997-10-22 三共株式会社 １，４―ジヒドロピリジン化合物

Also Published As

Publication number Publication date
FR2671349A1 (fr) 1992-07-10
AU648134B2 (en) 1994-04-14
AU1006992A (en) 1992-07-16
JPH07113016B2 (ja) 1995-12-06
DE69229607D1 (de) 1999-08-26
DE69229607T2 (de) 2000-03-09
GR3031173T3 (en) 1999-12-31
ATE182330T1 (de) 1999-08-15
FR2671349B1 (fr) 1993-04-23
KR920014780A (ko) 1992-08-25
DK0494816T3 (da) 2000-01-31
KR100225002B1 (ko) 1999-10-15
ES2136614T3 (es) 1999-12-01
JPH05148231A (ja) 1993-06-15
US5250543A (en) 1993-10-05
EP0494816B1 (fr) 1999-07-21
UA27719C2 (uk) 2000-10-16
EP0494816A1 (fr) 1992-07-15
HU9200069D0 (en) 1992-03-30
TW197420B (hu) 1993-01-01

Similar Documents

Publication Publication Date Title
ZA919181B (en) Oxazolopyridine derivatives,processes for preparing these and pharmaceutical compositions containing them
DE59108930D1 (de) Cyclische Iminoderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
GR3018212T3 (en) Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them.
CA2155673A1 (en) N-alkyl-2-substituted atp analogues
FI906307A0 (fi) Menetelmä terapeuttisesti aktiivisten pyrimidiinijohdannaisten valmistamiseksi
HUT56370A (en) Process for producing tricyclic carbapenem derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ZA935276B (en) 3-(hydroxybenzylidenyl)-indolin-2-ones processes for their preparation and pharmaceutical compositions containing them
ATE146473T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
ZA936658B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
HUT61009A (en) Process for producing 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient
HUP0103316A2 (hu) 2-Ureido-pirimidon-származékok, eljárás azok előállítására, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE32221T1 (de) 3 n-substituierte 3,4-dihydropyrimidinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
IL112102A0 (en) Annelated dihydropyridinoacetic acid derivatives, their preparation and pharmaceutical compositions containing them
DK0628042T3 (da) Serotoninerge ergolinderivater
GR3017599T3 (en) Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them.
DE69429753T2 (de) Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung
GR3024391T3 (en) Cyclised analogs of metabolites of fatty acids, process for their preparation and pharmaceutical compositions containing them.
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them
AT389309B (de) Malonsaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung, enthaltend diese verbindungen

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee